Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hemispherx BioPharma, Inc. (AMEX: HEB)

 
HEB Technical Analysis
5
As on 31st Oct 2017 HEB Share Price closed @ 0.31 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.52 & Strong Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

HEB Share Price

Open 0.31 Change Price %
High 0.31 1 Day 0.01 3.33
Low 0.30 1 Week 0.00 0.00
Close 0.31 1 Month -0.02 -6.06
Volume 219715 1 Year -0.60 -65.93
52 Week High 0.94 | 52 Week Low 0.30
 
AMEX USA Most Active Stocks
PAL 0.05 -50.00%
NGD 3.29 -6.80%
RBY 0.03 -70.00%
LODE 0.12 -7.69%
PBTH 8.23 0.37%
GGR 0.02 100.00%
VTG 0.05 -16.67%
SYRG 8.13 0.87%
GSX 0.02 0.00%
SHZ 0.10 -16.67%
 
AMEX USA Top Gainers Stocks
GGR 0.02 100.00%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
ATC 0.37 60.87%
MBA 0.20 25.00%
MBA 0.20 25.00%
MBA 0.20 25.00%
IG 7.68 22.49%
IG 7.68 22.49%
 
AMEX USA Top Losers Stocks
RBY 0.03 -70.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
PAL 0.05 -50.00%
QBC 0.20 -33.33%
LBY 6.84 -25.33%
ATL 0.06 -25.00%
ATL 0.06 -25.00%
SNT 0.12 -20.00%
INV 0.14 -17.65%
 
 
HEB
Daily Charts		 HEB
Intraday Charts		 Whats New @
Bazaartrend		 HEB
Free Analysis
 
HEB Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.32
RESISTANCE0.32
SUPPORT0.30
SUPPORT0.30
SUPPORT0.00
SUPPORT0.00
 
HEB Target for Month January
Share
4th UP TARGET0.44
3rd UP TARGET0.4
2nd UP TARGET0.37
1st UP TARGET0.35
1st DOWN TARGET0.27
2nd DOWN TARGET0.25
3rd DOWN TARGET0.22
4th DOWN TARGET0.18
 
HEB Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
HEB Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
HEB Other Details
Segment EQ
Market Capital 115221192.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
HEB Address
HEB
 One Penn Center
1617 JFK Boulevard
Philadelphia, PA 19103
United States
Phone: 215-988-0080
Fax: 215-988-1739
 
HEB Latest News
 
Your Comments and Response on Hemispherx BioPharma, Inc.
 
HEB Business Profile
Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the United States. The company products comprise Ampligen, an experimental drug, which is under clinical development for the treatment of chronic fatigue syndrome, Hepatitis B, HIV, renal cell carcinoma, and malignant melanoma. Its products also include Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza, seasonal influenza, and other emerging viruses. The company was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service